FDA Support for Conferences and Scientific Meetings (R13)

FDA Support for Conferences and Scientific Meetings (R13) from the FDA Center for Tobacco Products is a grant program that provides federal financial assistance for scientific conferences and meetings focused on tobacco regulatory science. The program aims to advance research, data sharing, and scientific dialogue on tobacco product regulation and its public health implications.

The R03 mechanism also supports new investigators in tobacco regulatory research through pilot studies, secondary data analyses, and feasibility studies. Eligible applicants include organizations and investigators working on issues aligned with FDA's tobacco regulatory mission. Grant amounts vary.

Skip to in this section menu Tobacco Science & Research Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) RFA-OD-25-008 This Notice of Funding Opportunity (NOFO) aims to support new biomedical, behavioral, and social science investigators who are in the early stages of establishing independent careers in tobacco regulatory research.

The R03 grant mechanism supports different types of projects, including pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, and development of new research technology. Applicants are encouraged to conduct projects that ultimately have the potential to inform regulations on tobacco product manufacturing, distribution, and marketing.

Research projects must address one or more High-Priority Research Topic(s) related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. Application due dates: November 18, 2025, and July 14, 2026.

FDA Support for Conferences and Scientific Meetings (R13) The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission.

The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission.

Application due dates: April 12, 2023; October 12, 2023; April 12, 2024; October 11, 2024; April 11, 2025; and October 10, 2025 by 11:59 p. m. EST.

In addition to supporting research through NIH's programs, CTP solicits proposals for research contracts administered by FDA. Those opportunities are published through the Federal Business Opportunities website and also posted on the CTP website.